These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 15274202)

  • 1. Effect of different LDL-apheresis methods on parameters involved in atherosclerosis.
    Hershcovici T; Schechner V; Orlin J; Harell D; Beigel Y
    J Clin Apher; 2004; 19(2):90-7. PubMed ID: 15274202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct adsorption of low-density lipoprotein and lipoprotein(a) from whole blood: results of the first clinical long-term multicenter study using DALI apheresis.
    Bosch T; Lennertz A; Schenzle D; Dräger J;
    J Clin Apher; 2002; 17(4):161-9. PubMed ID: 12494408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of two whole blood systems (DALI and Liposorber D) for LDL apheresis on lipids and cardiovascular risk markers in severe hypercholesterolemia.
    Otto C; Berster J; Otto B; Parhofer KG
    J Clin Apher; 2007; 22(6):301-5. PubMed ID: 17935245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One year experience with a low density lipoprotein apheresis system.
    Durst R; Rund D; Schurr D; Eliav O; Ben-Yehuda D; Shpizen S; Ben-Avi L; Schaap T; Pelz I; Leitersdorf E
    Isr Med Assoc J; 2002 Sep; 4(9):677-80. PubMed ID: 12440228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of DALI LDL-apheresis at high blood flow rates: a prospective multicenter study.
    Wendler T; Schilling R; Lennertz A; Sodemann K; Kleophas W; Messner H; Riechers G; Wagner J; Keller C; Bosch T
    J Clin Apher; 2003; 18(4):157-66. PubMed ID: 14699591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Practical aspects of direct adsorption of lipoproteins from whole blood by DALI LDL-apheresis.
    Bosch T
    Transfus Apher Sci; 2004 Oct; 31(2):83-8. PubMed ID: 15501411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of DALI-LDL-apheresis in two patients treated with the angiotensin II-receptor 1 antagonist losartan.
    Bosch T; Wendler T
    Ther Apher Dial; 2004 Aug; 8(4):269-74. PubMed ID: 15274676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct adsorption of low-density lipoprotein by DALI-LDL-apheresis: results of a prospective long-term multicenter follow-up covering 12,291 sessions.
    Bosch T; Gahr S; Belschner U; Schaefer C; Lennertz A; Rammo J;
    Ther Apher Dial; 2006 Jun; 10(3):210-8. PubMed ID: 16817783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dextran-sulfate-adsorption of atherosclerotic lipoproteins from whole blood or separated plasma for lipid-apheresis--comparison of performance characteristics with DALI and Lipidfiltration.
    Julius U; Parhofer KG; Heibges A; Kurz S; Klingel R; Geiss HC
    J Clin Apher; 2007; 22(4):215-23. PubMed ID: 17455220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct adsorption of lipoproteins (DALI) from whole blood: first long-term clinical experience with a new LDL-apheresis system for the treatment of familial hypercholesterolaemia.
    Jansen M; Banyai S; Schmaldienst S; Goldammer A; Rohac M; Hörl WH; Derfler K
    Wien Klin Wochenschr; 2000 Jan; 112(2):61-9. PubMed ID: 10703153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The first case report of the treatment of transplant coronary artery disease with dextran sulfate adsorption lipid apheresis.
    Sosland RP; Gollub SB; Wilson DB; Moriarty PM
    Ther Apher Dial; 2010 Apr; 14(2):218-21. PubMed ID: 20438545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LDL apheresis: a novel technique (LIPOCOLLECT 200).
    Stefanutti C; Di Giacomo S; Mazzarella B; Castelli A
    Artif Organs; 2009 Dec; 33(12):1103-8. PubMed ID: 19995360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LDL-apheresis reduces P-Selectin, CRP and fibrinogen -- possible important implications for improving atherosclerosis.
    Kobayashi S; Oka M; Moriya H; Maesato K; Okamoto K; Ohtake T
    Ther Apher Dial; 2006 Jun; 10(3):219-23. PubMed ID: 16817784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid reductions by low-density lipoprotein apheresis: a comparison of three systems.
    Jovin IS; Taborski U; Stehr A; Müller-Berghaus G
    Metabolism; 2000 Nov; 49(11):1431-3. PubMed ID: 11092506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct adsorption of lipoproteins from whole blood by direct adsorption of lipoprotein apheresis: first experience in two hypercholesterolemic children.
    Bayrakci US; Besbas N; Ozcebe O; Coskun T; Akgul E; Kutluk T; Bakkaloglu A
    Ther Apher Dial; 2005 Dec; 9(6):469-72. PubMed ID: 16354278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective randomised cross-over comparison of three LDL-apheresis systems in statin pretreated patients with familial hypercholesterolaemia.
    Schmaldienst S; Banyai S; Stulnig TM; Heinz G; Jansen M; Hörl WH; Derfler K
    Atherosclerosis; 2000 Aug; 151(2):493-9. PubMed ID: 10924726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute effects of LDL-apheresis on cholesterol oxidation products and antioxidants in plasma and lipoproteins of patients with familial hypercholesterolemia.
    Linseisen J; Wilhelm M; Hoffmann J; Hailer S; Keller C; Wolfram G
    Eur J Med Res; 1999 Oct; 4(10):433-41. PubMed ID: 10527957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of hyperlipidemia with a modified low density lipoprotein apheresis system with dextran sulfate.
    Zhao YH; Zou YG; Sun QJ; Xi D; Xing CY
    Ther Apher Dial; 2007 Aug; 11(4):249-54. PubMed ID: 17661829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term follow-up of circulating oxidative stress markers in patients undergoing lipoprotein apheresis by Direct Adsorption of Lipids (DALI).
    Kopprasch S; Bornstein SR; Bergmann S; Graessler J; Hohenstein B; Julius U
    Atheroscler Suppl; 2017 Nov; 30():115-121. PubMed ID: 29096826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracorporeal plasma treatment for the removal of endotoxin in patients with sepsis: clinical results of a pilot study.
    Bengsch S; Boos KS; Nagel D; Seidel D; Inthorn D
    Shock; 2005 Jun; 23(6):494-500. PubMed ID: 15897800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.